VKH
ARRY

Virtu KCG Holdings’s Array Biopharma Inc ARRY Stock Holding History

Virtu KCG Holdings’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$181K Sell
21,670
-4,968
-19% -$40.6K 0.01% 2204
2017
Q1 		$238K Buy
26,638
+3,577
+16% +$38.1K 0.01% 2226
2016
Q4 		$203K Buy
+23,061
New +$170K 0.01% 2584
2016
Q3 		– Sell
-23,641
Closed -$84K – 3665
2016
Q2 		$84K Sell
23,641
-30,627
-56% -$99.8K ﹤0.01% 2575
2016
Q1 		$160K Sell
54,268
-56,003
-51% -$168K ﹤0.01% 2188
2015
Q4 		$465K Buy
110,271
+91,494
+487% +$418K 0.01% 1629
2015
Q3 		$86K Buy
18,777
+734
+4% +$4.35K ﹤0.01% 2875
2015
Q2 		$130K Sell
18,043
-32,783
-65% -$242K ﹤0.01% 2815
2015
Q1 		$375K Buy
50,826
+6,264
+14% +$44.6K 0.01% 1665
2014
Q4 		$211K Buy
44,562
+14,206
+47% +$56.2K ﹤0.01% 2827
2014
Q3 		$108K Sell
30,356
-31,470
-51% -$124K ﹤0.01% 3167
2014
Q2 		$281K Buy
61,826
+42,924
+227% +$178K ﹤0.01% 2648
2014
Q1 		$89K Buy
18,902
+6,187
+49% +$31.1K ﹤0.01% 3233
2013
Q4 		$64K Sell
12,715
-10,158
-44% -$55.3K ﹤0.01% 3552
2013
Q3 		$142K Buy
+22,873
New +$136K ﹤0.01% 3271

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Virtu KCG Holdings's ARRY Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Array Biopharma Inc (ARRY) stake by 19% in Q2 2017, selling an estimated $40.6K and leaving 21,670 shares worth $181K. The position accounts for 0.01% of the portfolio, ranked #2204.

Virtu KCG Holdings first reported a position in ARRY in Q3 2013 and has held it in 15 quarters since. The position peaked at $465K in Q4 2015. 182 funds tracked by Wall St. Rank hold ARRY as of Q2 2017.

  • Virtu KCG Holdings held 21,670 shares of Array Biopharma Inc worth $181K as of Q2 2017.
  • Virtu KCG Holdings sold 4,968 Array Biopharma Inc shares in Q2 2017, an estimated $40.6K.
  • Array Biopharma Inc made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2204 holding.
  • Virtu KCG Holdings first reported a position in Array Biopharma Inc in Q3 2013 and has held it in 15 quarters since.
  • Virtu KCG Holdings's Array Biopharma Inc position peaked at $465K in Q4 2015.
  • 182 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.